New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
12:15 EDTRNAProsensa shares up 7.5% to $6.32
Note that the company is appearing at the World Orphan Drug Congress.
News For RNA From The Last 14 Days
Check below for free stories on RNA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
08:03 EDTRNAProsensa extends re-dosing of drisapersen in Europe
Subscribe for More Information
September 24, 2014
08:06 EDTRNAProsensa publishes results of research into dystrophin in patients with DMD, BMD
Prosensa Holding announced that the results of its research into developing an accurate and reproducible method for the measurement of dystrophin in patients with Duchenne muscular dystrophy, or DMD, and Becker's muscular dystrophy, or BMD, have been published in the online peer reviewed journal PLOS ONE. This method has also been tested as part of an international consortium initiative, the Biochemical Outcome Measures study group, which focuses on the optimization of dystrophin assays.
08:06 EDTRNAProsensa publishes results of research into dystrophin in patients with DMD, BMD
Subscribe for More Information
07:03 EDTRNAProsensa initiated with a Neutral at Credit Suisse
Target $9.
September 18, 2014
08:25 EDTRNAProsensa weakness creates buying opportunity, says Oppenheimer
Subscribe for More Information
September 17, 2014
14:57 EDTRNAProsensa announces commencement of re-dosing of drisapersen
Subscribe for More Information
14:56 EDTRNAProsensa commences re-dosing of drisapersen in North America DMD patients

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use